LA-MERE APP. | BRAWN BIOTECH | LA-MERE APP./ BRAWN BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 90.1 | -3.8 | - | View Chart |
P/BV | x | 0.4 | 1.2 | 35.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
LA-MERE APP. BRAWN BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
LA-MERE APP. Mar-24 |
BRAWN BIOTECH Mar-24 |
LA-MERE APP./ BRAWN BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 68 | 27 | 253.7% | |
Low | Rs | 23 | 14 | 160.0% | |
Sales per share (Unadj.) | Rs | 2.8 | 55.0 | 5.1% | |
Earnings per share (Unadj.) | Rs | 0.5 | -4.2 | -12.2% | |
Cash flow per share (Unadj.) | Rs | 0.5 | -3.8 | -14.2% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 112.9 | 16.9 | 668.8% | |
Shares outstanding (eoy) | m | 5.00 | 3.00 | 166.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 16.2 | 0.4 | 4,334.4% | |
Avg P/E ratio | x | 89.8 | -5.0 | -1,813.7% | |
P/CF ratio (eoy) | x | 84.1 | -5.4 | -1,562.9% | |
Price / Book Value ratio | x | 0.4 | 1.2 | 33.0% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 227 | 62 | 368.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2 | 14 | 13.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 14 | 165 | 8.5% | |
Other income | Rs m | 6 | 1 | 730.7% | |
Total revenues | Rs m | 20 | 166 | 12.3% | |
Gross profit | Rs m | -3 | -15 | 19.0% | |
Depreciation | Rs m | 0 | 1 | 17.2% | |
Interest | Rs m | 0 | 1 | 0.0% | |
Profit before tax | Rs m | 3 | -15 | -22.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | -3 | -31.3% | |
Profit after tax | Rs m | 3 | -12 | -20.3% | |
Gross profit margin | % | -20.0 | -8.9 | 223.3% | |
Effective tax rate | % | 26.9 | 19.2 | 139.6% | |
Net profit margin | % | 18.1 | -7.6 | -239.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 19 | 131 | 14.7% | |
Current liabilities | Rs m | 0 | 65 | 0.5% | |
Net working cap to sales | % | 135.8 | 40.2 | 337.8% | |
Current ratio | x | 58.7 | 2.0 | 2,907.2% | |
Inventory Days | Days | 16,252 | 15 | 111,402.8% | |
Debtors Days | Days | 440 | 85,924 | 0.5% | |
Net fixed assets | Rs m | 629 | 10 | 6,338.2% | |
Share capital | Rs m | 50 | 30 | 166.7% | |
"Free" reserves | Rs m | 515 | 21 | 2,492.2% | |
Net worth | Rs m | 565 | 51 | 1,114.7% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 649 | 141 | 459.1% | |
Interest coverage | x | 0 | -25.6 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0 | 1.2 | 1.9% | |
Return on assets | % | 0.4 | -8.4 | -4.6% | |
Return on equity | % | 0.4 | -24.6 | -1.8% | |
Return on capital | % | 0.6 | -29.3 | -2.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -5 | 0 | 1,984.6% | |
From Investments | Rs m | 6 | NA | -5,066.7% | |
From Financial Activity | Rs m | NA | NA | -0.0% | |
Net Cashflow | Rs m | 1 | 0 | -219.0% |
Indian Promoters | % | 66.8 | 53.6 | 124.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.4 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 33.2 | 46.4 | 71.6% | |
Shareholders | 8,212 | 4,157 | 197.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare LA-MERE APP. With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | LA-MERE APP. | BRAWN PHARMA |
---|---|---|
1-Day | 2.08% | -1.28% |
1-Month | -2.00% | 6.57% |
1-Year | 44.20% | 17.62% |
3-Year CAGR | 20.08% | 3.00% |
5-Year CAGR | 50.96% | -2.03% |
* Compound Annual Growth Rate
Here are more details on the LA-MERE APP. share price and the BRAWN PHARMA share price.
Moving on to shareholding structures...
The promoters of LA-MERE APP. hold a 66.8% stake in the company. In case of BRAWN PHARMA the stake stands at 53.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LA-MERE APP. and the shareholding pattern of BRAWN PHARMA.
Finally, a word on dividends...
In the most recent financial year, LA-MERE APP. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
BRAWN PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of LA-MERE APP., and the dividend history of BRAWN PHARMA.
For a sector overview, read our textiles sector report.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.